Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Non-infectious uveitis is associated with visual impairment and blindness. Non-biologic treatment for non-infectious uveitis is not based on strong evidence. A retrospective chart review was conducted to investigate treatment response to high-dose intravenous methylprednisolone (IVMP) in children with non-infectious uveitis. Fifty-six patients (93 eyes affected) were included. In 29% uveitis was associated with juvenile idiopathic arthritis. Uveitis predominately affected the anterior segment, was bilateral and recurrent. Complications were common and included visual loss, synechiae, cataract and/or retinal lesions. Patients received up to 5 IVMP at monthly intervals. Visual acuity improved at 3 and 6 months. Anterior chamber cells, synechiae, keratic precipitates, papillary and/or macular edema improved at 3 months. Children treated with ≥3 IVMP (vs 1 IVMP) experienced trends towards fewer relapses, fewer cataracts and less frequently required treatment with biologic agents. High-dose IVMP induce rapid improvement in children with non-infectious uveitis. Prospective randomized trials are required to confirm results.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.clim.2019.108327 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Adalimumab in Focus: Evaluating Effectiveness and Safety in Non-Infectious Uveitis at a Tertiary Referral Center in Türkiye.
Turk J Ophthalmol
August 2025
Eye Protection Foundation, Bayrampaşa Eye Hospital, İstanbul, Türkiye.
Objectives: To evaluate the indications, efficacy, and safety of adalimumab (ADA) in treating active non-infectious uveitis (NIU) in the Turkish population in a real-world setting.
Materials And Methods: This retrospective observational study included patients diagnosed with NIU treated with ADA on-label. The study assessed the impact of ADA treatment on best corrected visual acuity (BCVA), number of immunosuppressive therapies (IST), immunosuppressive drug load, and the frequency of required local treatment.
The conjunctiva is a central component of the ocular mucosal system and, together with the Meibomian glands of the eyelids and the lacrimal glands, fulfills nutritive and defensive functions on the ocular surface. The conjunctiva is integrated into a dense neural and immunological network called the "Conjunctiva-associated Lymphoid Tissue" (CALT) 1 2. This network perceives various stimuli and responds in a finely tuned manner to provide protection while minimizing collateral damage.
View Article and Find Full Text PDFCyclosporine in uveitis: a game changer or a risky choice? A systematic review and meta-analysis of its efficacy and safety.
Br J Ophthalmol
August 2025
Department of Ophthalmology, Fu Jen Catholic University College of Medicine, New Taipei, Taiwan
Background: Uveitis, an inflammation of the uveal tract, can lead to severe ocular complications and vision loss if left untreated. Cyclosporine has gained recognition as an effective immunosuppressive therapy, particularly as a steroid-sparing agent. This study aims to evaluate the efficacy and safety of cyclosporine in managing various types of uveitis, assess its safety profile and associated adverse effects, and compare its therapeutic effectiveness to other treatment options.
View Article and Find Full Text PDFPredictors of uveitic macular edema and functional prognostic outcomes: real-life data from the international AIDA Network uveitis registry.
Front Med (Lausanne)
July 2025
Unit of Ophthalmology, Department of Medicine, Surgery, and Neurosciences, University of Siena and Azienda Ospedaliero-Universitaria Senese [European Reference Network (ERN) for Rare Immunodeficiency, Autoinflammatory, and Autoimmune Diseases (RITA) Center], Siena, Italy.
Objectives: To detect factors capable of predicting the development of macular edema (ME) throughout the disease course in patients affected by non-infectious uveitis (NIU).
Methods: Predictive factors leading to the development of ME were analyzed through regression analysis. The functional impact of ME on best corrected visual acuity (BCVA) was also examined.
Epidemiology and Clinical Features of Uveitis in Southwestern Japan: Laterality and Long-Term Visual Prognosis Based on the Anatomical and Epidemiological Classification.
Ocul Immunol Inflamm
July 2025
Miyata Eye Hospital, Miyakonojo, Japan.
Purpose: To investigate the epidemiology, clinical features, laterality, and long-term visual prognosis of uveitis.
Methods: This is a retrospective observational study.
Results: We included 1362 patients diagnosed with uveitis at Miyata Eye Hospital, Japan, from 2015 to 2020.